SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-23-007539
Filing Date
2023-03-10
Accepted
2023-03-10 16:26:28
Documents
113
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K akba-20221231.htm   iXBRL 10-K 3397951
2 EX-10.53 exhibit1053revised-akebiam.htm EX-10.53 24700
3 EX-10.70 exhibit1070-akebiabiovectr.htm EX-10.70 64844
4 EX-10.81 exhibit1081furtherrevised-.htm EX-10.81 483304
5 EX-23.1 exhibit231-eyakebiaconsent.htm EX-23.1 8882
6 EX-31.1 akbaex31112312022-10xk.htm EX-31.1 10994
7 EX-31.2 akbaex31212312022-10xk.htm EX-31.2 11075
8 EX-32.1 akbaex32112312022-10xk.htm EX-32.1 8359
14 akba-20221231_g1.jpg GRAPHIC 397781
  Complete submission text file 0001628280-23-007539.txt   15847322

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akba-20221231.xsd EX-101.SCH 117547
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akba-20221231_cal.xml EX-101.CAL 114468
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akba-20221231_def.xml EX-101.DEF 554171
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akba-20221231_lab.xml EX-101.LAB 1160781
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akba-20221231_pre.xml EX-101.PRE 802534
107 EXTRACTED XBRL INSTANCE DOCUMENT akba-20221231_htm.xml XML 2256249
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36352 | Film No.: 23724042
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences